Browse: Departments   Dates   Agencies  

NOTICE: NOTICES

ACTION: Applications, hearings, determinations, etc.:

SUBJECT CATEGORY: Importer of Controlled Substances; Notice of Registration

DOCUMENT SUMMARY:

By Notice dated July 31, 2007 and published in the Federal Register on August 9, 2007, (72 FR 44859), Almac Clinical Services Inc., (ACSI), 2661 Audubon Road, Audubon, Pennsylvania 19403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Oxycodone (9143)........................... II

Fentanyl (9801)............................ II

The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Almac Clinical Services Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Almac Clinical Services Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed.

Dated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant, Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E722512 Filed 111507; 8:45 am]
BILLING CODE 441009P

SUMMARY: Almac Clinical Services Inc.,

DOCUMENT BODY 2:

By Notice dated July 31, 2007 and published in the Federal Register on August 9, 2007, (72 FR 44859), Almac Clinical Services Inc., (ACSI), 2661 Audubon Road, Audubon, Pennsylvania 19403, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II:
Drug Schedule Oxycodone (9143)........................... II

Fentanyl (9801)............................ II

The company plans to import small quantities of the listed controlled substances in dosage form to conduct clinical trials.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Almac Clinical Services Inc. to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Almac Clinical Services Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed.

Dated: November 6, 2007.
Joseph T. Rannazzisi,
Deputy Assistant, Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E722512 Filed 111507; 8:45 am]
BILLING CODE 441009P